drugset / Trial / NCT00380874

Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer

NCT00380874

Phase 4 Terminated 64 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Prevention and treatment of the severity of symptoms of chemotherapy-induced peripheral neuropathy.

Timeline

Start
2007-01
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg
Subject Pregabalin Small molecule 600 mg